| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.61▼ | 5.57▲ | 5.57▼ | 5.59▼ | 5.30▲ |
| MA10 | 5.58▼ | 5.57▲ | 5.59▼ | 5.52▲ | 5.18▲ |
| MA20 | 5.59▼ | 5.56▲ | 5.52▲ | 5.32▲ | 5.37▲ |
| MA50 | 5.57▼ | 5.55▲ | 5.54▲ | 5.17▲ | 5.01▲ |
| MA100 | 5.59▼ | 5.52▲ | 5.38▲ | 5.57▲ | 3.36▲ |
| MA200 | 5.51▲ | 5.38▲ | 5.28▲ | 5.58▼ | 5.25▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.001▲ | 0.007▲ | 0.035▲ | -0.017▼ |
| RSI | 47.910▼ | 52.018▲ | 51.628▲ | 54.829▲ | 52.432▲ |
| STOCH | 82.937▲ | 33.347 | 54.556 | 72.253 | 60.058 |
| WILL %R | -45.238 | -61.017 | -36.364 | -27.638 | -15.235▲ |
| CCI | -77.328 | -55.122 | 30.777 | 69.964 | 158.351▲ |
|
Tuesday, April 14, 2026 12:17 AM
CEO Benjamin J. Zeskind told investors at a Needham conference session that 2026 has started with what he described as “extraordinary” early survival results for the company’s lead program, ...
|
|
Monday, April 13, 2026 01:44 PM
Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that ...
|
|
Monday, April 06, 2026 01:21 PM
About Immuneering Immuneering is a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive. The Company is developing an entirely new category of cancer ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/04/26 | 5.75 | 5.75 | 5.44 | 5.57 | 1,010,237 |
| 15/04/26 | 5.44 | 5.75 | 5.2513 | 5.75 | 893,606 |
| 14/04/26 | 5.75 | 5.83 | 5.39 | 5.41 | 994,042 |
| 13/04/26 | 5.52 | 5.845 | 5.4803 | 5.70 | 759,020 |
| 10/04/26 | 5.68 | 5.77 | 5.45 | 5.52 | 573,626 |
| 09/04/26 | 5.42 | 5.68 | 5.38 | 5.66 | 866,390 |
| 08/04/26 | 5.40 | 5.544 | 5.33 | 5.50 | 518,203 |
| 07/04/26 | 5.36 | 5.3675 | 5.18 | 5.23 | 932,988 |
| 06/04/26 | 5.47 | 5.58 | 5.32 | 5.40 | 656,389 |
| 02/04/26 | 5.19 | 5.59 | 5.19 | 5.45 | 597,449 |
|
|
||||
|
|
||||
|
|